Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 6, 2013, Pages 979-986

  Shaffi, Kamran ^a   Tighiouart, Hocine ^b   Scott, Tammy ^c   Lou, Kristina ^a   Drew, David ^a   Weiner, Daniel ^a   Sarnak, Mark ^a  

^a Division of Nephrology   (United States)

^b Boston Biostatistics   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATION; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPSYCHOLOGICAL TEST; QUESTIONNAIRE; SMOKING; SUN EXPOSURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BOSTON; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; LINEAR MODELS; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84878848494     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10651012     Document Type: Article

References (42)

1. Murray AM: Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 15: 123-132, 2008
2. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ: Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 30: 41-49, 1997
3. Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, Sarnak MJ: Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 58: 773-781, 2011
4. Kurella M,Chertow GM, Fried LF,Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K: Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 16: 2127-2133, 2005
5. Kurella Tamura M, Yaffe K: Dementia and cognitive impairment in ESRD: Diagnostic and therapeutic strategies. Kidney Int 79: 14-22, 2011
6. Jones G: Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 20: 316-324, 2007
7. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL: 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18-26, 2010
8. Coen G: Vitamin D: An old prohormonewith an emergent role in chronic kidney disease. J Nephrol 21: 313-323, 2008
9. Ibi M, Sawada H, Nakanishi M, Kume T, Katsuki H, Kaneko S, himohama S, Akaike A: Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40: 761-771, 2001
10. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM: Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21: 98-108, 2001
11. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007
12. Bhan I, Burnett-Bowie S-AM, Ye J, Tonelli M, Thadhani R: Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol 5: 460-467, 2010
13. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975
14. Wechsler D: Wechsler Adult Intelligence Scale, Third Edition (WAIS-III), San Antonio, Texas, Pearson, 1997
15. Heaton R, Grant I, Matthews C: Comprehensive Norms for an Expanded Halstead-Reitan Battery, Odessa, Florida, Psychological Assessment Resources Inc, 1991
16. Soylu F: Forward/Backward Digit-Span Task. Available at: http:// www.neurobs.com/ex_files/expt_view?id=218/. Accessed September 12, 2012
17. Jones BN, Teng EL, Folstein MF, Harrison KS: A new bedside test of cognition for patients with HIV infection. Ann Intern Med 119: 1001-1004, 1993
18. Benton A, Hamsher K: Multilingual Aphasia Examination: Manual of Instructions, Iowa City, Iowa, Department of Neurology and Psychology, University of Iowa, 1983
19. IDS PLC-A-Z List of Products. Available at: http://www.idsplc com/int/products/. Accessed September 12, 2012.
20. Ross CA, Taylor CL, Yaktine AL, Del ValleHB, editors; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D.Washington, DC, The National Academies Press, 2011
21. Tobin J: Estimation of relationships for limited dependent variables. Econometrica 26: 24-36, 1952
22. Joliffe IT, Morgan BJ: Principal component analysis and exploratory factor analysis. Stat Methods Med Res 1: 69-95, 1992
23. Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, Drew DA, Shaffi K, Strom JA, Singh AK, Weiner DE: Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology 80: 471-480, 2013
24. Webb AR, Kline L, Holick M F: Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure towinter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373-378, 1988
25. Clements MR, Davies M, Hayes ME, Hickey CD, Lumb GA, Mawer EB, Adams PH: The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (Oxf) 37: 17-27, 1992
26. Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Punab M, Silman AJ, Vanderschueren D,Wu FC; EMAS study group: Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 80: 722-729, 2009
27. McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic D:No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 29: 49-54, 2007
28. Anand S, Kaysen GA, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, Kurella Tamura M: Vitamin D deficiency, selfreported physical activity and health-related quality of life: The Comprehensive Dialysis Study. Nephrol Dial Transplant 26: 3683-3688, 2011
29. Vaidya A, Forman JP: VitaminDand vascular disease: The current and future status of vitaminDtherapy in hypertension and kidney disease. Curr Hypertens Rep 14: 111-119, 2012
30. Lee S-Y, Kim H-Y, Gu SW, Kim H-J, Yang DH: 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patientswith chronic kidney disease. Kidney Blood Press Res 35: 349-354, 2012
31. Assimon MM, Salenger PV, El-Fawal HA, Mason DL: Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit? Nephrology (Carlton) 17: 237-242, 2012
32. Oudshoorn C,Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM: Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 25: 539-543, 2008
33. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ: Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29: 21-30, 2005
34. Pardridge WM, Sakiyama R, Coty WA: Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 44: 1138-1141, 1985.
35. Hewison M: VitaminDand immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 243: 92-102, 2012
36. Pereira AA,Weiner DE, Scott T, Chandra P, Bluestein R, Griffith J, Sarnak MJ: Subcortical cognitive impairment in dialysis patients. Hemodial Int 11: 309-314, 2007
37. Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E: Mineral-bone metabolism markers in young hemodialysis patients. Clin Biochem 44: 1425-1428, 2011
38. Tomiyama C, Higa A, Dalboni MA, Cendoroglo M, Draibe SA, Cuppari L, Carvalho AB, Neto EM, Canziani MEF: The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 21: 2464-2471, 2006
39. Palmer SCHA, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 305: 1119-1127, 2011
40. Avram MM, Sreedhara R, Fein P, Oo KK, Chattopadhyay J, Mittman N: Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 37[Suppl 2]: S77-S80, 2001
41. Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, Miskulin DC:Disordered mineralmetabolismin hemodialysis patients: An analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis 52: 531-540, 2008
42. Vitamin D supplementation on physical and cognitive functionpilot study. ClinicalTrials.gov. Available at: http://clinicaltrials. gov/ct2/show/NCT01229878/. Accessed July 24, 2012